In the United States, a team of software developers in India, with the support of Johns Hopkins University, have developed a new smartphone app to guide people at home after conducting a positive test for COVID-19.
Bengalru, a V& + Svasa mobile app developed by V Technologies, provides educational videos, local medical care and COVID-19 vaccines, and other content available from medical professionals directly to the user’s smartphone. IT Services is headquartered in New York, with support from the Valipa Foundation. The developers have acquired content and medical professionals from the staff of Johns Hopkins University School of Medicine in the United States.
A group of about 100 students competed in the Sona College of Technology for a $ 1 million student award. The winning team from this competition – Saint Sivaraman S, Harsh Vardan SMS, Raguel P and Shreinik Jain U – have been selected to support the application development and running process.
“We have reached out to the Johns Hopkins Institute of India to provide internationally accepted care protocols. This is extremely important,” said Choko Valipa, trustee of the Valipa Foundation.
Home quarantine app has a lot of accurate information on self-medication, self-isolation, how to protect others in the family, how to measure oxygen saturation for parents, and easy-to-understand COVID-19 treatment. Flow chart.
The information and health protocols provided in the application are sourced only from reputable sources such as Johns Hopkins University, the Indian Medical Research Council (ICMR) and the Indian Institute of Medical Sciences (AIIMS).
“We are concerned about the rapid response of Johns Hopkins Medicine International President and CEO VP Dr Mohan Chelapa and his Indian counterparts to help us access access to internationally recognized nursing equipment.”
In addition, the app provides existing services to state governments to connect hospital beds, immunization centers and capitals by telecommunications.
The app is available in the Google Play Store. The iOS version of the app will launch soon.